Conagen’s New Dihydro Resveratrol Made By Clean Bioconversion Inspires Novel Products and Drives Market Growth
Bedford, Mass., May 31, 2022 (GLOBE NEWSWIRE) — Massachusetts-based biotech Conagen announces the development of a new scalable natural compound, dihydro resveratrol, for use in industrial and human health applications. Conagen’s dihydro resveratrol is made by bioconversion from p-coumaric acid (pCA), a natural preservative Conagen produced by precision fermentation. The same proprietary bioconversion technology used […]
Continue Reading